Medtronic PLC is trading 4.58% up at $77.13 after reporting fourth-quarter results that beat revenue expectations and delivered its highest annual revenue growth in a decade.

  • The company posted $9.8 billion in Q4 revenue and $1.55 non-GAAP EPS, with full-year fiscal 2026 revenue reaching $36.4 billion.
  • Organic revenue growth for the fiscal year stood at 5.8%, reflecting strong performance across its core business segments.
  • The move aligns with pre-earnings market positioning that anticipated a 4.1% price swing ahead of the June 3 earnings release.